Ken Griffin Candel Therapeutics Inc

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$1.16

Avg closing price
Price range
Ken Griffin Portfolio Stock Details (CADL)

7 Ken Griffin Candel Therapeutics Trades

The first Candel Therapeutics trade was made in Q3 2022. Since then Ken Griffin bought shares two more times and sold shares on four occasions. The investor completely sold their stake between Q4 2023 and Q1 2024.

Avg closing price
Price range
Sold -16.9 Thousand shares Q1 2024
Avg closing price $1.48
Price range $1.20 - $1.86
Sold 47.6% shares (-15.3 Thousand shares) Q4 2023
Avg closing price $0.97
Price range $0.68 - $1.47
New holding (+32.2 Thousand shares) Q3 2023
Avg closing price $1.16
Price range $0.91 - $1.30
Sold -47.2 Thousand shares Q2 2023
Avg closing price $1.48
Price range $1.20 - $1.78
New holding (+47.2 Thousand shares) Q1 2023
Avg closing price $1.95
Price range $1.35 - $2.72
Sold -16.9 Thousand shares Q4 2022
Avg closing price $1.98
Price range $1.48 - $3.20
New holding (+16.9 Thousand shares) Q3 2022
Avg closing price $3.39
Price range $3.05 - $4.08
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.